Cargando…

Progestogen-only oral contraceptives: Number 4 - April 2022

Detalles Bibliográficos
Autores principales:	Machado, Rogério Bonassi, Politano, Carlos Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948109/ https://www.ncbi.nlm.nih.gov/pubmed/35623623 http://dx.doi.org/10.1055/s-0042-1748754

Ejemplares similares

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
por: Kulier, Regina, et al.
Publicado: (2004)

Contraceptive counseling during the pandemic: practical guidelines: Number 7 - July 2021
por: Filho, Edson Santos Ferreira, et al.
Publicado: (2021)

From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
por: Han, Leo, et al.
Publicado: (2017)

Hormonal Contraceptives and Risk of Breast Cancer: How to Explain it without Controversy
por: Machado, Rogério Bonassi
Publicado: (2018)

The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial
por: Cameron, Sharon T, et al.
Publicado: (2020)

Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022)

Different Perceptions among Women and Their Physicians Regarding Contraceptive Counseling: Results from the TANCO Survey in Brazil
por: Machado, Rogério Bonassi, et al.
Publicado: (2020)

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
por: van Hylckama Vlieg, A, et al.
Publicado: (2009)

ODP644 Oral Dosing of Progestogenic Androgens for Male Contraception Show Low Serum Testosterone and High Acceptability in Placebo-Controlled Trials
por: Jacobsohn, Tamar, et al.
Publicado: (2022)

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
por: Lidegaard, Øjvind, et al.
Publicado: (2011)

Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015)

Bridging progestogens in pregnancy and pregnancy prevention
por: Micks, Elizabeth, et al.
Publicado: (2015)

Estimates of mpox effective reproduction number in Spain, April–August 2022
por: García-García, David, et al.
Publicado: (2023)

Long-Acting Reversible Contraception
por: Machado, Rogerio Bonassi, et al.
Publicado: (2017)

The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage
por: Arab, Hisham, et al.
Publicado: (2019)

Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?
por: Xia, Zhi, et al.
Publicado: (2021)

In the literature: April 2022
por: Ciardiello, D., et al.
Publicado: (2022)

49-April 2022
Publicado: (2022)

The April Number
Publicado: (1889)

Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial
por: Hofmeyr, G Justus, et al.
Publicado: (2017)

In this Issue: Volume 113, Issue 4, April 2022
Publicado: (2022)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
por: Shen, Ye, et al.
Publicado: (2022)

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens
por: Ørbo, A, et al.
Publicado: (2015)

The Role of Progestogens in Threatened and Idiopathic Recurrent Miscarriage [Corrigendum]
Publicado: (2020)

INTERPRETIVE SUMMARIES, APRIL 2022
Publicado: (2022)

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study
por: Briggs, Paula, et al.
Publicado: (2016)

The Use of Progestogen in the Treatment of Metastatic Carcinoma of the Kidney and Uterine Body
por: Paine, C. H., et al.
Publicado: (1970)

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
por: Coombes, Zoe, et al.
Publicado: (2020)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

FIGO good practice recommendations on progestogens for prevention of preterm delivery
por: Shennan, Andrew, et al.
Publicado: (2021)

Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support
por: Tetruashvili, Nana, et al.
Publicado: (2023)

Estro-progestin and progestogen intake: What’s the impact on hysteroscopic imaging?
por: Garuti, G, et al.
Publicado: (2023)

Errata in April Number
Publicado: (1861)

Our April Number
Publicado: (1896)

CERN Courier Volume 4, Number 4, April 1964
por: CERN
Publicado: (1964)

Accurate diagnosis of breast lesions: Number 4 – April 2023
por: Andrade, Alexandre Vicente de, et al.
Publicado: (2023)

Controversies in the Use and Periodicity of Mammography as a Screening Method for Breast Cancer
por: Machado, Rogério Bonassi
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bbbshid35flo060m28h4mgqkla